Related Experiment Video
Updated: Jan 16, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Pi*M Palermo Mutation in Bronchiectasis due to Alpha-1 Antitrypsin Deficiency: A Rare Genetic Cause
Beyza Yildirimli1, Coskun Dogan1, Elif Yilmaz Gulec2
1Istanbul Medeniyet University Faculty of Medicine, Department of Pulmonology, Istanbul, Türkiye.
Abstract:
Bronchiectasis, defined as the permanent dilation of the bronchial wall, is a chronic inflammatory disease with nearly thirty known causes. The most common cause is recurrent and inadequately treated lower respiratory tract infections. Among the rarer causes is alpha-1 antitrypsin (AAT) deficiency, an anti-protease and anti-inflammatory protein deficiency. To date, approximately 500 variants of AAT deficiency have been identified, with the PI*S and PI*Z mutations being the most commonly associated with bronchiectasis. Here, we present a case diagnosed with bronchiectasis secondary to AAT deficiency during an advanced clinical workup, in which the rare Pi*M Palermo mutation was identified. This case is discussed in the context of the existing literature.
Insights
Bronchiectasis, a chronic lung disease, can stem from rare genetic conditions like alpha-1 antitrypsin (AAT) deficiency. This case highlights the Pi*M Palermo mutation as a previously unrecognized cause of AAT deficiency-related bronchiectasis.
Area of Science:
- Pulmonology
- Genetics
- Internal Medicine
Background:
- Bronchiectasis is a chronic inflammatory lung disease with numerous causes, commonly linked to infections.
- Alpha-1 antitrypsin (AAT) deficiency is a rare genetic cause, characterized by reduced levels of the AAT protein, which protects lungs from inflammation.
- Commonly identified AAT deficiency mutations associated with bronchiectasis include PI*S and PI*Z.
Purpose of the Study:
- To report a case of bronchiectasis attributed to a rare variant of alpha-1 antitrypsin (AAT) deficiency.
- To highlight the Pi*M Palermo mutation as a potential cause of AAT deficiency-related bronchiectasis.
- To discuss this case within the existing scientific literature on AAT deficiency and lung disease.
Main Methods:
- Advanced clinical workup was performed for a patient diagnosed with bronchiectasis.
- Genetic analysis was conducted to identify the specific mutation associated with alpha-1 antitrypsin (AAT) deficiency.
- Literature review was performed to contextualize the findings.
Main Results:
- A diagnosis of bronchiectasis secondary to alpha-1 antitrypsin (AAT) deficiency was established.
- The rare Pi*M Palermo mutation in AAT deficiency was identified in the patient.
- This finding expands the known spectrum of AAT deficiency mutations causing bronchiectasis.
Conclusions:
- The Pi*M Palermo mutation represents a novel genetic cause of alpha-1 antitrypsin (AAT) deficiency-related bronchiectasis.
- Genetic screening for AAT deficiency should be considered in patients with unexplained bronchiectasis.
- Further research is warranted to understand the prevalence and clinical significance of rare AAT deficiency mutations.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-I: Introduction
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...

